» Articles » PMID: 32048877

What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial

Abstract

We explored health professionals' views about the training, support, and resourcing needed to support people using closed-loop technology in routine clinical care to help inform the development of formal guidance. Interviews were conducted with health professionals ( = 22) delivering the Closed Loop from Onset in Type 1 Diabetes (CLOuD) trial after they had ≥6 months' experience of supporting participants using a closed-loop system. Data were analyzed descriptively. Interviewees described how, compared with other insulin regimens, teaching and supporting individuals to use a closed-loop system could be initially more time-consuming. However, they also noted that after an initial adjustment period, users had less need for initiating contact with the clinical team compared with people using pumps or multiple daily injections. Interviewees highlighted how a lessened need for ad hoc clinical input could result in new challenges; specifically, they had fewer opportunities to reinforce users' diabetes knowledge and skills and detect potential psychosocial problems. They also observed heightened anxiety among some parents due to the constant availability of data and unrealistic expectations about the system's capabilities. Interviewees noted that all local diabetes teams should be empowered to deliver closed-loop system care, but stressed that health professionals supporting closed-loop users in routine care will need comprehensive technology training and standardized clinical guidance. These findings constitute an important starting point for the development of formal guidance to support the rollout of closed-loop technology. Our recommendations, if actioned, will help limit the potential additional burden of introducing closed-loop systems in routine clinical care and help inform appropriate user education and support.

Citing Articles

The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands.

de Jongh D, Bunnik E, Ozcan B, Zietse R, Massey E J Clin Transl Endocrinol. 2024; 38:100372.

PMID: 39502713 PMC: 11536005. DOI: 10.1016/j.jcte.2024.100372.


Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: Qualitative study.

Lawton J, Rankin D, Hartnell S, Lee T, Dover A, Reynolds R Diabet Med. 2023; 40(5):e15072.

PMID: 36807582 PMC: 10947358. DOI: 10.1111/dme.15072.


Closed-loop insulin delivery: update on the state of the field and emerging technologies.

Ware J, Hovorka R Expert Rev Med Devices. 2022; 19(11):859-875.

PMID: 36331211 PMC: 9780196. DOI: 10.1080/17434440.2022.2142556.


Parents' views about healthcare professionals having real-time remote access to their young child's diabetes data: Qualitative study.

Kimbell B, Rankin D, Hart R, Allen J, Boughton C, Campbell F Pediatr Diabetes. 2022; 23(6):799-808.

PMID: 35561092 PMC: 9544441. DOI: 10.1111/pedi.13363.


AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol.

Lee T, Collett C, Man M, Hammond M, Shepstone L, Hartnell S BMC Pregnancy Childbirth. 2022; 22(1):282.

PMID: 35382796 PMC: 8982306. DOI: 10.1186/s12884-022-04543-z.


References
1.
Pope C, Mays N . Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995; 311(6996):42-5. PMC: 2550091. DOI: 10.1136/bmj.311.6996.42. View

2.
Hendrieckx C, Poole L, Sharifi A, Jayawardene D, Loh M, Horsburgh J . "It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017; 19(7):410-416. DOI: 10.1089/dia.2017.0007. View

3.
Barnard K, Wysocki T, Ully V, Mader J, Pieber T, Thabit H . Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy. J Diabetes Sci Technol. 2017; 11(6):1080-1088. PMC: 5951034. DOI: 10.1177/1932296817702656. View

4.
Perry L, James S, Gallagher R, Dunbabin J, Steinbeck K, Lowe J . Supporting patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Difficulties, disconnections, and disarray. J Eval Clin Pract. 2017; 23(4):719-724. DOI: 10.1111/jep.12703. View

5.
Lawton J, Blackburn M, Rankin D, Allen J, Campbell F, Leelarathna L . The impact of using a closed-loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents. Diabet Med. 2018; 36(6):753-760. PMC: 6510609. DOI: 10.1111/dme.13887. View